MedVasc Funding News -Swedish MedTech Startup MedVasc Raises €917k Funding

The funding round included both current shareholders and new investors.

The recent investment will support the production and testing of Solutio’s final design, a key step toward FDA clearance, which MedVasc plans to apply for in the first half of 2026.

The company also plans to raise another funding round in 2025 to support additional clinical and preclinical work required for FDA approval.

“We are very pleased with the continued confidence from our investors,” says Cathrin Johansson, CEO of MedVasc AB. “This investment gives us the opportunity to take decisive steps towards reaching the US market, which is an important milestone in our growth journey.”

MedVasc AB was founded in 2013 by Michael Åkesson. Over the past few years, the company has developed a final prototype of its device, secured patents and trademarks in key markets, and completed a first-in-human clinical study.

Åkesson is a senior consultant in interventional radiology with over 20 years of experience in catheter-based treatments. He previously led the Division of Endovascular Surgery at the University Hospital SUS in Malmö and currently works at the Scandinavian Venous Centre in Malmö.

Read More - Rockaway Ventures Closes €55M Fund To Back Transformative Tech

He is the main owner of MedVasc AB and the inventor of the company’s flagship device, Solutio.

MedVasc has developed and patented a medical device called Solutio, created to improve how anesthesia is delivered during varicose vein treatments. It is currently for investigational use only and has not yet been evaluated by the FDA or approved for sale in the U.S.

Solutio enables safe and accurate local anesthesia during minimally invasive vascular procedures, such as those for varicose veins. It’s compatible with thermal ablation treatment fibers and is designed to give doctors better control while enhancing patient comfort.

MedVasc is part of SmiLe’s incubator program in Lund. SmiLe is a leading venture hub focused on helping life science and FoodTech startups grow. Its program has supported over 110 startups, which together have raised more than €1.05 billion in funding and completed 21 IPOs.

About MedVasc AB

MedVasc AB is a MedTech company based in Lund, Sweden, founded in 2013 by Michael Åkesson. The company specializes in developing and commercializing medical devices, with a focus on improving treatments for varicose veins.